×
Volver a Agenda
Session Chair(s)
Robert Feeney, MBA
Head, North America Public Policy Services
Sanofi, United States
Learning Objective : Describe opportunities to bridge the regulatory and industry gap; Identify how industry and other stakeholders increase faster clinical trial enrollment and enhance data collection; Discuss examples where patients/industry/regulatory collaborated, thus advancing therapies.
Speaker(s)
Panelist
Cynthia A Bens
Personalized Medicine Coalition, United States
Senior Vice President, Public Policy
Panelist
Francesca Cerreta, PHARMD, MPHARM, MS
European Medicines Agency, Netherlands
Principal Scientific Officer
Panelist
Drew Holzapfel, MBA
The Global CEO Initiative On Alzheimer's Disease, United States
Executive Director
¿Tiene una cuenta?